Clinical Trials Logo

Osteoarthritis, Knee clinical trials

View clinical trials related to Osteoarthritis, Knee.

Filter by:

NCT ID: NCT00850538 Completed - Clinical trials for Osteoarthritis, Knee

Role of Bone in Knee Osteoarthritis (OA)

Start date: July 2008
Phase: N/A
Study type: Observational

The purpose of the study is to investigate protein and gene expression among damaged knee tissues. We will perform MRI's on subjects prior to total knee replacement to identify the location of bone marrow lesions. Connective tissues including tendon, ligament, and meniscus specimens normally discarded from total joint replacements will be used for live cell harvest, and protein and gene expression analyses of tissue or cultured cells.

NCT ID: NCT00850187 Completed - Knee Osteoarthritis Clinical Trials

Autologous Transplantation of Mesenchymal Stem Cells (MSCs) and Scaffold in Full-thickness Articular Cartilage

Start date: August 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the efficacy and safety of autologous transplantation of Bone Marrow Mesenchymal stem cells (MSCs) mixed with collagen I scaffold in patient with Knee cartilage defects and osteoarthritis

NCT ID: NCT00837772 Completed - Clinical trials for Osteoarthritis of the Knee

Total Knee Replacement Study Using Standard Cutting Guide vs Otismed MRI Generated Cutting Guide

Start date: January 2008
Phase: N/A
Study type: Interventional

Patients are referred to the VA orthopedic surgical clinic because of osteoarthritis and are requesting consideration for a total knee replacement. Those who qualify for the knee replacement are informed about the study. Those who consent to participate are randomly assigned to either the standard cutting guide or to the new method which is a MRI generated cutting guide called Otismed. All patients have an MRI so both groups will be unaware of which surgical technique is used. All patients receive the usual pre-op care and same type of replacement knee. Follow-up research visits are scheduled at 4 weeks, 3 and 6 months, and 1 and 2 years. Patients will be informed of which surgical technique they were randomized to at the conclusion of the study.

NCT ID: NCT00834483 Completed - Knee Osteoarthritis Clinical Trials

Use of Knotless Suture for Closure of Total Hip and Knee Arthroplasties

Start date: February 2009
Phase: N/A
Study type: Interventional

Barbed sutures offer several potential advantages in layered wound closure of hip and knee replacement surgeries. It use is gaining increased acceptance across many of the other surgical disciplines at this time. The purpose of this study is to evaluate the use of Quill as part of our layered closure compared to using our traditional sutures. The study timeline begins at the time of the surgical procedure and continues through the routine follow-up of total joint replacements at 2, 6, and 12 weeks, and will conclude at the six month post-operative office visit. Primary Objectives: - To evaluate the safety and efficacy of wound closure in primary hip and knee replacements using a bidirectional barbed suture (knotless) compared to a traditional layered (vicryl) wound closure. Secondary Objectives: - Establish the all around (intra-operative and post-operative) cost-savings potential in using a knotless wound closure compared to that of a layered vicryl closure (our standard suture protocol). - Assess the overall cosmesis of the wound/scar as well as perceived presence of subcutaneous surgical knots, when using the knotless wound closure versus our traditional layered suture closure.

NCT ID: NCT00833911 Completed - Clinical trials for Osteoarthritis, Knee

An Open-Label Long-term Safety Study of Tramadol HCl OAD (Once A Day) 300 mg in the Treatment of Pain Due to Osteoarthritis of the Knee

Start date: April 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to collect information regarding the long-term (6 and 12 months) safety of Tramadol HCl Once-A-Day(OAD) 300 mg.

NCT ID: NCT00832416 Completed - Pain Clinical Trials

A Four-Arm Study Comparing the Analgesic Efficacy and Safety of Tramadol Once a Day 100, 200 and 300 mg Versus Placebo for the Treatment of Pain Due to Osteoarthritis of the Knee

Start date: January 2003
Phase: Phase 3
Study type: Interventional

The purpose of this study is to compare the analgesic efficacy and safety of Tramadol Once a Day 100, 200, 300 mg and Placebo

NCT ID: NCT00830063 Completed - Osteoarthritis Clinical Trials

Tanezumab In Osteoarthritis Of The Knee (2)

Start date: May 5, 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to test the efficacy and safety of 2 doses of tanezumab compared with naproxen and placebo in patients with osteoarthritis.

NCT ID: NCT00823888 Completed - Clinical trials for Osteoarthritis, Knee

Mechanics of Knee Bracing

Start date: September 2008
Phase: N/A
Study type: Interventional

The overall objective of this project is to determine whether the provision of a pneumatic knee brace in patients with medial knee osteoarthritis (OA) improves knee mechanics. Secondary objectives will be to assess if the brace relieves knee pain and improves function. We will test the hypothesis that compared to the control treatment (see below for the definition) the use of a pneumatic knee brace is effective in medial knee OA.

NCT ID: NCT00820430 Completed - Clinical trials for Osteoarthritis, Knee

MRI Markers of Cartilage Damage in Knee With Osteoarthritis

Start date: November 2006
Phase:
Study type: Observational

The objectives of this study are: to identify and develop techniques to minimize precision errors in magnetic resonance imaging (MRI) evaluation of knee cartilage, and to determine if results from newly-identified MRI techniques in measuring cartilage changes and structure can be reproduced.

NCT ID: NCT00819572 Completed - Osteoarthritis Clinical Trials

Study of Intra-articular DLX105 Applied to Patients With Severely Painful Osteoarthritis of the Knee

Start date: December 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to determine whether an intra-articular injection of DLX105 to the knee joint of patients suffering from severly painful osteoarthritis is safe and reduces pain.